eli lilly glp-1 agonist Lilly's Next-Generation GLP-1R Naperiglipron—Structure Revealed FDA just approved orforglipron (Foundayo),

doi: 10.1097/MNH.0b013e328350313e

For short-acting, daily administered GLP-1RAs, cessation on the day of surgery is advised

It is important to note that receptor desensitization, feedback suppression, and compensatory signaling are by no means unique to peptidesthese phenomena are well documented for small-molecule drugs, including beta-blockers, opioids, and statins

88 Although the absolute risk appears low, several surgical societies recommend precautionary withholding of GLP-1 RAs prior to elective procedures

After eating, GLP-1 blood concentrations rise by 2-4-fold, activated by neuroendocrine pathways (with onset 1015 min after eating) and nutrient-specific G-protein coupled intestinal receptors (with onset 3060 min after eating) [260]

In addition, nausea may be reduced by eating smaller portions